Louisville’s Medicaid spending on chemotherapy drug services reaches $10,282,102 in 2024

In 2024, Louisville Medicaid providers submitted $10,282,102 in claims for services in the Chemotherapy Drugs category, data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show. This amount reflects a 1.8% uptick compared to 2023, when $10,102,918 was billed for the same service category.

Medicaid functions as a public health program managed by states and financed collectively by state and federal governments. It insures low-income populations, elderly residents, children, and those with disabilities, ranking among the largest components of America’s health care safety net.

Because taxpayer dollars support Medicaid payments, trends in local billing reflect how public funds for health care are spent in a given area.

The Chemotherapy Drugs category includes a set of Medicaid-billable services defined by type of treatment, using established HCPCS and CPT code groupings. For these findings, every applicable billing code was grouped into a single service category using established coding areas and number ranges, ensuring related services are analyzed consistently while preventing duplication and maintaining consistent ranking over time.

While multiple service categories saw increases in Medicaid spending, Chemotherapy Drugs ranked as the 10th largest in Louisville by total Medicaid dollars during 2024.

Statewide in Kentucky, Chemotherapy Drugs came in 13th by Medicaid payments in 2024.

Medicaid spending for Chemotherapy Drugs in Louisville climbed by $5,431,249 over five years through 2024, up 112%. Growth was especially pronounced during certain periods, showing notable annual rises in both 2022 and 2023.

Though Chemotherapy Drug services were billed across Louisville, payments were centered in a small number of ZIP codes. In 2024, ZIP code 40202 saw payments totaling $10,245,985 and 40215 had $36,116. These top 2 ZIP codes together made up 100% of Medicaid payments for Chemotherapy Drugs in the city that year.

A small subset of individual billing codes accounted for the majority of Medicaid payments within the Chemotherapy Drugs category.

Comparing years, Medicaid spending for Chemotherapy Drug services in Louisville increased 1.8% from 2023 to 2024. This contrasts with an 11% increase across all Medicaid claim categories citywide during the same interval.

Data from the Centers for Medicare & Medicaid Services indicate that national federal and state Medicaid spending reached around $871.7 billion in fiscal year 2023, which was nearly 18% of overall U.S. health expenditures. This represents a substantial increase from an estimated $613.5 billion in 2019, before COVID-19.

This change shows an approximate 40% rise in just a few years, mainly due to expanded enrollment and higher usage during and after the pandemic.

Federal budget legislation enacted during the Trump administration introduced major proposals to reduce federal Medicaid funding and change program structure. As an example, the “One Big Beautiful Bill Act,” signed into law in 2025, is estimated to reduce federal Medicaid spending by over $1 trillion in the next decade. This law implements work requirements and increases cost-sharing—policies that may cut coverage and funding for portions of the beneficiary population. As a result, greater financial responsibility may fall on states, potentially restricting growth in federal Medicaid funding, although the program continues to provide coverage to tens of millions of Americans.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.